Cardioprotective effects of sodium ferulate mediated by nitric oxide on ischemia-reperfusion injured myocardium: Experiment with isolated rat hearts

National Medical Journal of China

Volumn 86, Issue 14, 2006, Pages 987-991

  Liu, Ji Chun ^a   Kang, Jian ^a   Shao, Li Jian ^a   He, Ming ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

Guanosine 3 , 5 cyclic monophosphate; K+ ATP channel; Nitric oxide; Reperfusion injury; Sodium ferulate

Indexed keywords

CYCLIC GMP; FERULIC ACID; GLIBENCLAMIDE; MALONALDEHYDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; OXYGEN RADICAL; POTASSIUM CHANNEL; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; ENZYME ACTIVITY; ENZYME ANALYSIS; HEART INFARCTION PREVENTION; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART RATE; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; INCIDENCE; NONHUMAN; RANDOMIZATION; RAT; REPERFUSION INJURY; STATISTICAL SIGNIFICANCE;

ANIMALS; CARDIOTONIC AGENTS; COUMARIC ACIDS; CYCLIC GMP; ENZYME INHIBITORS; FEMALE; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL REPERFUSION INJURY; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PERFUSION; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33745445912     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Murry CE, Jenning RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation, 1986,74:1124-1136.
2. Murphy E. Primary and secondary signaling pathways in early preconditioning that converge on the mitochondria to produce cardioprotection. Circ Res, 2004,94:7-16.
3. Lochner A, Marais E, Genade S, et al. Nitric oxide: a trigger for classic preconditioning. Am J Physiol Heart Circ Physiol, 2000, 279:H2752-H2765.
4. Chinese source. 2000,31:841-843.
5. Chinese source. 2003,19:1034-1036.
6. Chinese source. 1993,20:412-415.
7. Yellon DM, Downey JM. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev, 2003,83:1113-1151.
8. Chinese source. 2004,20:2330-2335.
9. Chinese source. 1994,9:36-38.
10. Chinese source. 2004,39:325-327.
11. Chinese source. 2003,13:28-30.
12. Chinese source. 1998,11:688-690.
13. Jefferey M, Park TS, Giddy JM, et al. Modulation of basal and postischemic leukocyte-endothelial adherence by nitric oxide. Stroke, 1998,29:1423-1430.
14. Pabla R, Buda AJ, Flynn PM, et al. Intracoronary nitric oxide improves postischemic coronary blood flow and myocardial contractile function. Am J Physiol, 1995,269:1113-1121.
15. Schulz R, Kelm M, Heusch G. Nitric oxide in myocardial ischemia/ reperfusion injury. Cardiovasc Res, 2004,61:402-413.
16. Wang Y, Haider HK, Ahmad N, et al. Mechanisms by which K (ATP) channel openers produce acute and delayed cardioprotection. Vascul Pharmacol, 2005,42:253-264.
17. Hanley PJ, Daut J. K(ATP) channels and preconditioning: a re-examination of the role of mitochondrial K(ATP) channels and an overview of alternative mechanisms. J Mol Cell Cardiol, 2005,39: 17-50.
18. Shiono N, Rao V, Weisel RD. L-arginine protects human heart cells from low-volume anoxia and reoxygenation. Am J Physiol Heart Circ Physiol, 2002,282:H805-815.